Previous 10 | Next 10 |
The shares of contract research organization Syneos Health, Inc. ( NASDAQ: SYNH ) dropped ~13% in the morning hours Tuesday after the company projected its Book-to-Bill ratio in the Clinical Solutions business could reach 1.05x – 1.15x for the 12-months ending Sep. ...
MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe and Chief Financial Officer Jason Meggs are scheduled to present at the...
Summary Bruker Corporation has done alright from an operational perspective, with sales continuing to rise modestly this year. Foreign currency is an issue right now and profits have contracted, posing investors some risk. Although shares are getting cheaper, they do still loo...
Syneos Health, Inc. (SYNH) Q2 2022 Earnings Conference Call August 2, 2022 09:00 a.m. ET Company Representatives Michelle Keefe - Chief Executive Officer Jason Meggs - Chief Financial Officer Michael Brooks - Chief Operating Officer Ronnie Speight - Senior Vi...
Gainers: AMTD IDEA ( AMTD ) +350% . AMTD Digital ( HKD ) +96% . Ostin Technology Group ( OST ) +67% . 36Kr Holdings ( KRKR ) +60% . Intelligent Living ( ILAG ) +41% . Liberty TripAdvisor ( LTRPB ) +40% . United Ti...
Syneos Health ( NASDAQ: SYNH ) stock fell ~17% on Aug. 2, after the company cut its FY22 outlook to reflect lower expected reimbursable expenses in its Clinical Solutions segment and increased impact of foreign currency exchange rate fluctuations. Q2 adjusted EPS grew +2...
The following slide deck was published by Syneos Health, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Syneos Health, Inc. 2022 Q2 - Results - Earnings Call Presentation
Syneos Health press release ( NASDAQ: SYNH ): Q2 Non-GAAP EPS of $1.25 beats by $0.06 . Revenue of $1.36B (+6.3% Y/Y) misses by $30M . For further details see: Syneos Health Non-GAAP EPS of $1.25 beats by $0.06, revenue of $1.36B misses by $30M
Revenue for the second quarter of $1,360.7 million increased 6.1% on a reported basis and 8.3% on a constant currency basis year-over-year. Clinical Solutions net new business awards and book-to-bill ratios: Including reimbursable out-of-pocket expenses, $947.4 million for the s...
Syneos Health ( NASDAQ: SYNH ) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, before market open. The consensus EPS Estimate is $1.19 (+22.7% Y/Y) and the consensus Revenue Estimate is $1.39B (+8.6% Y/Y). Over the last 2 years, SYNH has beaten E...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...